VTR
Get informed when a big investor buys or sells
+ FollowApril 28, 2026 - AI Summary
Undervalued by 40.9% based on the discounted cash flow analysis.
| Market cap | $41.04 Billion |
|---|---|
| Enterprise Value | $53.58 Billion |
| Dividend Yield | $1.96 (2.32%) |
| Earnings per Share | $0.55 |
| Beta | 0.76 |
| Outstanding Shares | 476,185,000 |
| P/E Ratio | 154.36 |
|---|---|
| PEG | 0 |
| Price to Sales | 6.59 |
| Price to Book Ratio | 2.93 |
| Enterprise Value to Revenue | 8.74 |
| Enterprise Value to EBIT | 133.5 |
| Enterprise Value to Net Income | -1494 |
| Total Debt to Enterprise | 0.24 |
| Debt to Equity | 0.97 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.3329▲ 10.66% |
|---|---|
| Total Calls | 655,700▼ 9.06% |
| Total Puts | 218,300▲ 33.76% |
Holdings and activity of institutional investors.
| Ownership % | 109.24%▲ 2.63% |
|---|---|
| Total Invested | $40.67B▲ 8.07% |
| Investors Holding | 940▼ 1.00% |
No data
Controls federal tax policy (impacting REIT structure and profitability) and critical entitlement spending, particularly Medicare and Medicaid, which are major revenue sources for Ventas's healthcare facility tenants.
Directly controls federal spending, including significant allocations for healthcare programs (Medicare/Medicaid) and medical research, which are critical revenue sources for Ventas's tenants and influence demand for its properties.
Directly regulates the healthcare sector (FDA, NIH) and labor laws. Decisions on labor costs and healthcare policy significantly affect the operational expenses and profitability of Ventas's healthcare facility tenants.
Directly regulates the financial system, including the SEC (which oversees REITs) and real estate markets (HUD). Its decisions on financial regulations and interest rates profoundly impact Ventas's cost of capital, property valuations, and financial viability.